Home > Urology > No benefit of dose-intensified salvage radiation for prostate-cancer recurrence

No benefit of dose-intensified salvage radiation for prostate-cancer recurrence


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Conference
ASCO 2021 Genitourinary Cancers Symposium
Reuters Health - 22/02/2021 - Dose-intensified salvage radiotherapy is not superior to conventional dose salvage RT and is associated with increased late rectal toxicity in patients with biochemical recurrence of prostate cancer after prostatectomy, according to new findings. "The results tell us more is not always better," Dr. Neeraj Agarwal of Huntsman Cancer Institute, in Salt Lake City, said in a statement from the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, where the research was presented. "In this study of men with recurrence of prostate cancer after surgery, standard dose of radiation was as effective as the higher dose of radiation therapy in controlling the disease, and was less toxic," said Dr. Agarwal, who was not involved in the study. Radical prostatectomy is the standard primary treatment for localized prostate cancer. However, up to 40% of patients will experience biochemical progression following surgery. For...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on